We blend heart, science and ingenuity to profoundly change the trajectory of health for humanity.
We are driven by Our Credo, a set of values and principles that challenges and inspires us to put the needs and wellbeing of the people we serve first.
We operate 97 manufacturing facilities which are located in all major geographic regions of the world. Research facilities are located in the United States, Belgium, Brazil, China, France, Germany, India, Israel, the Netherlands, Poland, Singapore, Sweden, Switzerland and the United Kingdom, with additional R&D support in over 30 other countries.
Our global headquarters are in New Brunswick, New Jersey, USA. Johnson & Johnson has been listed on the New York Stock Exchange since 1944 under the symbol JNJ. For changes in our business during the reporting period, please visit page 79 of our 2019 Annual Report.
On September 24, 1944, Johnson & Johnson was first listed as a publicly traded company on the New York Stock Exchange (NYSE). The Company was founded in 1886 and had already established itself as a successful business for almost 60 years. Taking it public created an opportunity for people to invest in a company with a vision of healthcare, expanding the frontiers of Johnson & Johnson geographically and scientifically, to deliver health and healing globally, propelled by significant breakthroughs in science, technology, and medicine.
The collective commitment and efforts of our global Johnson & Johnson colleagues throughout the decades have enabled great achievements and strong results, evidenced by:
Every day, we touch more than a billion lives with our products. Following are select brands that represent the diversity of the Johnson & Johnson product portfolio in our three business segments, spanning the broad continuum of healthcare.